Date Filed | Type | Description |
08/23/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
08/08/2023 |
8-K
| Quarterly results |
07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/03/2023 |
8-K
| Quarterly results |
04/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
03/01/2023 |
8-K
| Quarterly results |
02/07/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
02/02/2023 |
8-K
| Quarterly results |
01/31/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.1% stake in BIO-TECHNE CORPORATION |
01/20/2023 |
SC 13G
| BlackRock Inc. reports a 10.1% stake in BIO-TECHNE CORPORATION |
11/07/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/01/2022 |
8-K
| Quarterly results |
09/14/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
09/14/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
09/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
09/01/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
08/24/2022 |
10-K
| Annual Report for the period ended June 30, 2022 |
08/05/2022 |
8-K
| Quarterly results |
08/04/2022 |
8-K
| Quarterly results |
05/31/2022 |
SD
| Form SD - Specialized disclosure report: |
05/09/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/04/2022 |
8-K
| Quarterly results |
04/27/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/07/2022 |
10-Q
| Quarterly Report for the period ended December 31, 2021 |
02/01/2022 |
8-K
| Quarterly results |
01/27/2022 |
SC 13G/A
| BlackRock Inc. reports a 11% stake in BIO TECHNE CORPORATION |
01/25/2022 |
SC 13G/A
| BlackRock Inc. reports a 11% stake in BIO TECHNE CORPORATION |
12/22/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
11/08/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
|